81 results
8-K
EX-99.1
tmlvtb2iib srcd
14 May 20
Navidea Biopharmaceuticals Reports First Quarter 2020 Financial Results
4:09pm
424B3
hq08p64
24 May 21
Prospectus supplement
4:02pm
8-K
EX-99.1
j1t hwydq9z9udz6kg
16 Dec 21
Navidea Biopharmaceuticals Terminates Stock Purchase Agreement
4:46pm
8-K
EX-99.1
e92tpuih
5 May 21
Navidea Biopharmaceuticals Announces Changes to Board of Directors Composition
5:05pm
8-K
EX-99.1
5faa014p3xt15
26 Oct 21
Navidea Biopharmaceuticals Announces Resignation of Jed A. Latkin
5:26pm
8-K
EX-99.1
eshbdi9sma5x x38f
17 Sep 21
Navidea Biopharmaceuticals Announces Changes to Board of Directors Composition
8:00am
8-K
EX-99.2
iv5wyej6uf6955ih
2 Sep 22
Termination of a Material Definitive Agreement
4:16pm
8-K
EX-99.1
5n91l8c
9 Dec 21
Navidea Biopharmaceuticals Announces Business Update Call and Changes to Board of Directors Composition
4:09pm
8-K
EX-99.1
0on2jt
16 Jun 23
Navidea Biopharmaceuticals, Inc. Announces Distribution of Series K Preferred Stock to Holders of its Common Stock
5:22pm